Sign up Australia
Proactive Investors - Run By Investors For Investors

Amryt Pharma signs exclusive Saudi Arabian distribution agreement

Dave Allmond, chief commercial officer at  Amryt Pharma PLC (LON:AMYT), discusses with Proactive the exclusive distribution agreement they've signed with Saudi Arabian firm Faisal Musaed El Seif Saudi Pharmaceutical Company.

The deal gives El Seif the right to distribute Amryt’s Lojuxta and AP101 drugs in the kingdom.

 
Meet Great Boulder Resources Ltd, Mainstream Group Holdings Ltd, Blackstone Minerals Ltd, Pacific American Coal Ltd and Reward Minerals Ltd at our event, Sydney , 19 November 2018. Register here »
View full AMYT profile View Profile

Amryt Pharma PLC Timeline

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use